-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Kirsten Canté-Barrett, PhD1, Rui D Mendes1*, Wilco K Smits1*, Rob Pieters, MD, PhD1,2 and Jules PP Meijerink, PhD1

1Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
2Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Malgorzata Gozdecka, PhD1*, Milena M. Mazan, PhD1*, Vivek Iyer1*, Anna Farne1*, Eshwar Meduri2*, Ruben Bautista1*, Nicolas Walker3*, Anne C Ferguson-Smith, PhD3*, George S. Vassiliou, MD, PhD1* and Brian J.P Huntly, MD, PhD4*

1Wellcome Trust Sanger Institute, Cambridge, United Kingdom
2Cambridge Institute for Medical Research, Cambridge, United Kingdom
3Department of Genetics, University of Cambridge, Cambridge, United Kingdom
4Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom

Kathryn Black, PhD1*, Elena Sotillo, PhD1*, Nicole Martinez2*, Matthew Gazzara2*, Alejandro Barrera3*, Yoseph Barash, PhD3*, Kristen Lynch, PhD2* and Andrei Thomas-Tikhonenko, PhD4

1Cancer Pathobiology, The Children's Hospital of Philadelphia, Philadelphia, PA
2Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA
3Genetics, University of Pennsylvania, Philadelphia, PA
4Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA

Jung-Hyun Kim, Ph.D.*, Thomas W. Butler, MD and Eun-Young Erin Ahn, PhD

Mitchell Cancer Institute, University of South Alabama, Mobile, AL

Akanksha Verma1*, Yanwen Jiang, PhD1,2*, Lauren Fairchild1*, Wei Du, BS1*, Ari M. Melnick, MD3 and Olivier Elemento4*

1Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY
2Department of Medicine, Weill Cornell Medical College, New York, NY
3Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY
4Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY

Simone Riedel, Ph.D.1*, Jessica Haladyna, BA2*, Brett Stevens3*, Craig T Jordan, PhD4, Daniel Pollyea, MD, MS4, Scott A. Armstrong, MD, PhD5, Qi Wei, PhD6*, Patricia Ernst, PhD7, Tobias Neff, MD1 and Kathrin M Bernt, MD8

1Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO
2Department of Pediatrics, Hematology/Oncology/BMT, University of Colorado Denver, Aurora, CO
3University of Colorado, Aurora, CO
4Division of Hematology, University of Colorado School of Medicine, Aurora, CO
5Memorial Sloan-Kettering Cancer Center, New York, NY
6UC Denver, Aurora, CO
7Anschutz Medical Campus-Pediatrics, University of Colorado, Denver, Aurora, CO
8Pediatrics, University of Colorado Denver, Aurora, CO

Lauren Suarez1*, Tingting Qin, PhD2*, Kristen Meldi, PhD2*, Manjusha Thakar1*, Sarah Sakoian3*, Jonathan M. Gerber, MD4, Gabriel Ghiaur, MD, PhD1, Hetty E. Carraway, MD, MBA5, Maria E Figueroa, MD6 and Steven D. Gore, MD7

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
3Johns Hopkins University School of Medicine, Baltimore, MD
4Department of Hematologic Oncology and Blood Disorders, The Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC
5Leukemia Program, Cleveland Clinic, Cleveland, OH
6Pathology, University of Michigan, Ann Arbor, MI
7Yale University School of Medicine, New Haven, CT

Rui Lu, PHD1*, Ping Wang, PHD2*, Trevor Parton1*, Deyou Zheng, PHD2* and Gang Greg Wang, PhD1

1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
2Departments of Genetics and Neuroscience, Albert Einstein College of Medicine, Bronx, NY

Reem Karmali, MD, MS1, Annesha Basu2*, Jeffrey A Borgia3*, Leo I. Gordon, MD4, Parameswaran Venugopal, MD1 and Casey A Frankenberger3*

1Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL
2Rush University Medical Center, Chicago, IL
3Departments of Pathology and Biochemistry, Rush University Medical Center, Chicago, IL
4Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL

Nadja Blagitko-Dorfs1*, Pascal Schlosser2*, Dietmar Pfeifer1* and Michael Lübbert1

1Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany
2Institute for Medical Biometry and Statistics, University Medical Center Freiburg, Freiburg Im Breisgau, Germany

Milena M. Mazan, PhD1*, Malgorzata Gozdecka, PhD1*, Emmanouil Metzakopian, PhD1*, Konstantinos Tzelepis, MSc1*, Brian J.P Huntly, MD, PhD2,3,4* and George S. Vassiliou, MD, PhD1*

1Wellcome Trust Sanger Institute, Cambridge, United Kingdom
2Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom
3Cambridge Institute for Medical Research, Cambridge, United Kingdom
4Haematology, University of Cambridge, Cambridge, United Kingdom

Jatinder K Lamba, Ph.D1, Stanley Pounds2*, Xueyuan Cao2*, Susana C. Raimondi, PhD3, James R. Downing, MD3, Raul C Ribeiro4 and Jeffrey Rubnitz4

1Department of Pharmacotherapy and Translational Research College of Pharmacy, University of Florida, Gainesville
2Biostatistics, St Jude Children's Research Hospital, Memphis, TN
3Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
4Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN

Akihiko Yokoyama, PhD and Hiroshi Okuda, Ph.D.*

Kyoto University Graduate School of Medicine, Kyoto, Japan

Christopher C. Oakes, PhD1,2*, Marc Seifert3*, Yassen Assenov4*, Lei Gu5*, Martina Przekopowitz3*, Amy S. Ruppert, MAS6*, Qi Wang4*, Charles Imbusch4*, Andrius Serva4*, Sandra Koser4*, David Brocks4*, Daniel B Lipka7*, Olga Bogatyrova4*, Benedikt Brors4*, Dieter Weichenhan4*, Laura Z. Rassenti, PhD8, Thomas J. Kipps, MD, PhD9, Daniel Mertens, PhD10*, Marc Zapatka4*, Peter Lichter4*, Hartmut Döhner, MD11, Ralf Kueppers3*, Thorsten Zenz12*, Stephan Stilgenbauer, MD13, John C Byrd, MD14 and Christoph Plass, PhD2*

1The Ohio State University, Columbus, OH
2Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany
3The University of Duisburg-Essen, Essen, Germany
4The German Cancer Research Center (DKFZ), Heidelberg, Germany
5Harvard University, Boston
6Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
7Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany
8Moores UCSD Cancer Center, CLL Research Consortium, La Jolla, CA
9University of California, San Diego, La Jolla, CA
10Department of Internal Medicine III, University of Ulm, Ulm, Germany
11Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
12NCT/ German Cancer Research Center, Heidelberg, Germany
13Department of Internal Medicine III, University Hospital, Ulm, Germany
14Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH

Kerstin Maria Kampa-Schittenhelm, MD1*, Hans-Joerg Buehring2*, Michael Bonin2*, Wichard Vogel, MD3*, Lothar Kanz, Prof. Dr. med.4, Thomas Haverkamp5* and Marcus M Schittenhelm, MD6

1Department of Oncology, Hematology, Rheumatology, Immunology and Pulmology, University of Tuebingen, Tuebingen, Germany
2University of Tuebingen, Tuebingen, Germany
3Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
4Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
5MVZ, Dortmund, Germany
6Dept. of Oncology, Hematology, Rheumatology, Immunology and Pulmology, University of Tuebingen, Tuebingen, Germany

Dennis Gerloff1*, Alexander Arthur Wurm1*, Jens-Uwe Hartmann1*, Nadja Hilger2*, Anne-Marie Müller2*, Christiane Katzerke, PhD1*, Daniela Bräuer-Hartmann1*, Carolina Yaeko Namasu, MSc1*, Michael Cross, PhD1*, Sebastian Schwind, MD1, Knut Krohn, PhD3*, Stephan Fricke, MD2*, Dietger Niederwieser, MD4 and Gerhard Behre, MD5*

1Division of Hematology and Clinical Oncology, University Hospital Leipzig, Leipzig, Germany
2Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany
3Interdisciplinary Center for Clinical Research (IZKF), University Hospital Leipzig, Leipzig, Germany
4University Hospital of Leipzig, Leipzig, Germany
5Hematology and Oncology, University of Leipzig, Leipzig, Germany

Na Xu, MD1*, Yuling Li1*, Xuan Zhou, MD1*, Hongqian Zhu, MD2*, Lin Li1*, Qisi Lu1*, Rui Cao1*, Huan Li1*, Qifa Liu, MD1 and Liu Xiaoli, MD1

1Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, The People's Hospital of Guizhou Province, Guiyang, China

Tian Yuan, PhD1,2*, Yaling Yang, PhD1*, Jeffrey You3,4*, Daniel Lin, BS1,5*, Kefeng Lin1,6*, Yizhuo Zhang, MD2* and M. James You, MD, PhD1

1Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX
2Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
3Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX
4Texas A & M University, College Station, TX
5Washtington University at St. Louis, St. Louis, MO
6Chongqing Medical University, Chongqing, China

*signifies non-member of ASH